Astrana Health, Inc. filed a Form 8-K on September 15, 2026, under Regulation FD, disclosing that the company updated its corporate presentation for use at conferences and meetings.

Key Highlights

  • Updated presentation: Astrana Health updated its corporate presentation on September 15, 2026, for use at conferences and meetings.
  • Exhibit attached: The updated investor presentation slides are attached as Exhibit 99.1 to the filing.
  • Furnished, not filed: According to the filing, the information "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934."
  • No update commitment: The company disclosed it "does not undertake to update the information contained in the attached presentation materials."
  • Signed by CEO: The filing was signed by Brandon K. Sim, Chief Executive Officer and President.

Astrana Health Furnishes September 2026 Investor Presentation Under Regulation FD

Astrana Health, Inc. (NASDAQ:ASTH), a Delaware-incorporated healthcare company headquartered in Alhambra, California, filed a current report on September 15, 2026, to disclose an updated corporate presentation under Item 7.01 (Regulation FD Disclosure). According to the filing, the company intends to use the presentation "in connection with presentations at conferences and meetings." The slides are incorporated into the filing by reference as Exhibit 99.1, described as the "Investor Presentation (September 2026)."

The filing specifies that the furnished information, including the exhibit, "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934" and is not subject to the liabilities of that section. The company further stated the information will not be incorporated by reference into any other filing under the Securities Act of 1933 or the Exchange Act, and that furnishing the information "will not be deemed an admission as to the materiality of any information contained herein."

The filing also contains a forward-looking statements notice, identifying that certain statements may include words such as "forecast," "guidance," "projects," "estimates," "anticipates," and similar terms. The company noted that "forward-looking statements involve certain risks and uncertainties, and actual results may differ materially" from those discussed, and that it does not undertake responsibility to update those statements. The report was signed by Brandon K. Sim, Chief Executive Officer and President, on September 15, 2026.

What Was Disclosed

Astrana Health furnished an updated corporate investor presentation, attached as Exhibit 99.1, for use at conferences and meetings. The disclosure was made under Regulation FD on September 15, 2026, and is not deemed filed for Exchange Act liability purposes.